Recombinant vaccine Live attenuated vaccine
Human Papilloma
Herpes Zoster
d
✔ ✔
✔ ✔
✔
✔
b, e, f
✔
✔
b, e, f
✔ ✔
✔ ✔
✔
Not recommended
e
,
i
✔
Not recommended
e
,
i
f
e ACR conditionally recommends giving the herpes zoster vaccine before the patient receives
biologic therapy or tofacitinib for their RA in both early or established RA patients aged 50 and
over. e panel also voted that aer giving the herpes zoster vaccine, there should be a 2-week
waiting period before starting biologics.
g
Response to certain killed vaccines may be reduced aer rituximab therapy.
h
e ACR strongly recommends that in patients with early or established RA who are currently
receiving biologics, appropriately indicated killed/inactivated vaccines should be used.
i
e ACR conditionally recommends that in early or established RA patients who are currently
receiving biologics, live attenuated vaccines such as the herpes zoster (shingles) vaccine should not
be used.
13
